1Jennette C, Falk R, Andrassy K et al. Nomenclature of systemic vasculitides. Proposal of an international consensus conference [ J ]. Arthritis Rheum, 1994,37(2) : 187.
2Rai A, Nast C, Adler S. Henoch-Schonlein purpura nephritis[J]. J Am Soc Nephrol, 1999,10(12) :2637.
4Coppo R, Amore A, Gianoglio B. Clinical features of Henoch-Schonlein purpura Italian Group of Renal Immunopathology [ J ]. Ann Med Inteme (Paris), 1999,150(2) : 143.
5Davin JC,Woening JJ. Diagonosis of Henoch-Schonlein purpura: renal of skin biopsy[J]. Pediatrics Nephrol,2003,18(12) : 1201.
7Schlondorff D, Ndson PJ,Luckow Bet al. Chemokines and renal disease [J]. Kidney Int, 1997,51:610.
8Ronkainen J, Autio-Harmainen H,Nautinen M. Cydosporin A for the treatment of severe Henoch-Schonlein glomerulonephritis[ J]. Pedlatr Nephrol, 2003,18(5) :471.
2[1] Glassock RJ, Cohen AH. Secondary glomerular disease. In: Brenner BM, Retor Jr Fc. The kidney[M]. Vol, 4thed, Philadelphia: Sanun ders WB, 1991:1298.
3[2] Schlondorff D, Nelson PJ, Luckow B, et al. Chemokines and renal disea se[J]. Kidney Int, 1997,51:610-621.
4[3] Tang WW, Qi MY, Warren JS, et al. Chemokines expression in experitmen tal tubuolointerstitial nephritis[J]. J Immunol, 1997,159:870-876.
5[4] Wenzel U, Schneider A, Valente AJ, et al. Monocyte chemoattractant pr otein-1 mediates monocyte/macrophage influx in anti-thymocyte antibody-induce d glomerulonephritis[J]. Kidney Int, 1997,51:770-776.
6[5] Lloyd CM, Minto AW, Dorf ME, et al. Rantes and monocyte chemoattracta nt protein-1(MCP-1) play an important role in the inflammatory phase of crescn etic nephritis, but only MCP-1 is involed in crescent formation and interstitia l fibrosis[J]. J Exp Med, 1997,185(7):1371-1380.
8Jennette C,Falk R,Andrassy K,et al.Nomenclature of systemic vasculitides.Proposal of an international consensus conference.Arthritis Rheum,1994,37(2):187-192.
9Rai A,Nast C,Adler S.Adler S Henoci-Schonlein purpura nephritis.J Am Soc Nephrol,1999,10 (12):2637-2643.
